Comparative Study of N-Butyl-2-Cyanoacrylate and Indirect Reduction for Management of Comminuted Fracture
Background: Various studies in the past have shown that the butyl cyanoacrylate (CA) chemical group has shown the best results in terms of toleration by tissues. Aim: To compare and evaluate the efficacy of N-butyl-2-CA and IR with no fixation in the management of CF of AWMS. Material and Method: A...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-06-01
|
| Series: | Journal of Pharmacy and Bioallied Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jpbs.jpbs_1891_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background:
Various studies in the past have shown that the butyl cyanoacrylate (CA) chemical group has shown the best results in terms of toleration by tissues.
Aim:
To compare and evaluate the efficacy of N-butyl-2-CA and IR with no fixation in the management of CF of AWMS.
Material and Method:
A total of 26 samples were included in our study to understand clinically and radiographically CAWFMS with two different groups, that is, A as control and B as test with different follow-ups.
Result:
With regard to clinical aspect, for pain, the difference between groups was nonsignificant at 1 month and 3 months while significant for 1 week. For swelling and FBR, the difference was nonsignificant for all the follow-ups. With regard to radiographical aspect, ARSF, the difference was nonsignificant immediately but significant after 3 months, and at SP, the difference was significant at both immediate and 3 month follow-ups.
Conclusion:
Our study was in favor of the use of N-butyl-CAG for management of AWMS in patients with ZMC fractures due to its biocompatibility and effectiveness during the treatment. |
|---|---|
| ISSN: | 0976-4879 0975-7406 |